News & Events

November 18, 2020

BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights

CRESSKILL, N.J. and JERUSALEM, Israel, November 18, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 11, 2020

BrainsWay Announces Publication of New Real-World OCD Data for its Deep TMS System in Journal of Psychiatric Research

Additional data on first non-invasive medical device cleared by the FDA for OCD demonstrated that 73%...

November 4, 2020

BrainsWay to Report Third Quarter 2020 Financial Results and Operational Highlights on November 18, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, November 4, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 2, 2020

BrainsWay to Participate in Two Upcoming Investor Conferences

CRESSKILL, N.J. and JERUSALEM, Israel, November 2, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

October 13, 2020

BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)

In conjunction with OCD Awareness Week, BrainsWay partners with mental health influencers and patients...

October 6, 2020

BrainsWay Deep TMS Takes Center Stage at Clinical TMS Society Annual Poster Session

Deep TMS highlighted in 10 presentation posters at annual session

September 8, 2020

BrainsWay to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

CRESSKILL, N.J. and JERUSALEM, Israel, September 8, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

September 2, 2020

BrainsWay Announces Presentations at Upcoming Investor Conferences

CRESSKILL, N.J. and JERUSALEM, Israel, September 2, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

August 24, 2020

BrainsWay Receives FDA Clearance for Smoking Addiction in Adults

Company Intends to Execute a Controlled U.S. Market Release in Early 2021 This is the Company’s third...

August 12, 2020

BrainsWay Reports Second Quarter 2020 Financial Results and Operational Highlights

CRESSKILL, N.J. and JERUSALEM, Israel, August 12, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

July 29, 2020

BrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

July 21, 2020

BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020

PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

June 24, 2020

BrainsWay Reports First Quarter 2020 Financial Results and Operational Highlights

PATTERSON, N.J. and JERUSALEM, Israel, June 24, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

June 16, 2020

BrainsWay Launches New Website to Enhance Mental Health Awareness

New site features user-friendly layout, easy access to resources, and tools for those affected by COVID-19

June 11, 2020

BrainsWay Announces Participation in a Virtual Fireside Chat at the Raymond James 2020 Human Health Innovation Conference

PATTERSON, N.J. and JERUSALEM, Israel, June 11, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ &...

June 9, 2020

BrainsWay to Report First Quarter 2020 Financial Results and Operational Highlights on June 24, 2020

PATTERSON, N.J. and JERUSALEM, Israel, June 9, 2020 — BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

May 20, 2020

BrainsWay Strengthens Senior Leadership Team with Appointment of Christopher Boyer as Vice President of Global Marketing

PATTERSON, N.J., May 20, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...